Literature DB >> 9803334

Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances.

W Schmidt1, A Walther, M M Gebhard, E Martin, H Schmidt.   

Abstract

OBJECTIVES: To determine the influence of N-acetylcysteine (NAC) in a treatment model, its effects on endotoxin-induced leukocyte-endothelial cell adhesion, vascular leakage, and venular microhemodynamics in postcapillary venules of rat mesentery.
DESIGN: Prospective, randomized, controlled, experimental study.
SETTING: Animal research laboratory.
SUBJECTS: 40 male Wistar rats.
INTERVENTIONS: The rats randomly received one of four treatments: infusion of saline (SAL) or Escherichia coli lipopolysaccharides (LPS) followed by treatment with saline (SAL) or NAC (150 mg.kg-1 body weight) 30 min after induction of endotoxemia.
MEASUREMENTS AND MAIN RESULTS: Leukocyte adherence, red blood cell velocity, and vessel diameters in postcapillary venules of rat mesentery were evaluated every 30 min over a period of 120 min using in vivo videomicroscopy. Vascular permeability was determined by measuring the extravasation of fluorescence-labeled albumin. Venular wall shear rate was calculated from red cell velocity, and vessel diameter. NAC in rats without endotoxemia (SAL + NAC group) compared to the control group (SAL + SAL) did not change microcirculatory parameters in postcapillary venules of rat mesentery. In both LPS-treated groups (LPS + SAL and LPS + NAC), leukocyte adherence increased after just 30 min. NAC treatment prevented a further increase in leukocyte adherence and attenuated the extravasation of fluorescence-labeled albumin during endotoxemia. Venular diameters remained unchanged, while erythrocyte velocity decreased in the LPS + SAL group. This led to a lower venular wall shear rate in this group.
CONCLUSIONS: Treatment with NAC attenuates endotoxin-induced leukocyte adherence and macromolecular leakage in postcapillary venules of rat mesentery, showing that NAC is also effective after the onset of endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9803334     DOI: 10.1007/s001340050697

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

1.  N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo.

Authors:  H Schmidt; W Schmidt; T Müller; H Böhrer; M M Gebhard; E Martin
Journal:  Crit Care Med       Date:  1997-05       Impact factor: 7.598

Review 2.  Endothelial and leukocyte activation in experimental polytrauma and sepsis.

Authors:  H Redl; A Nikolai; R Kneidinger; G Schlag
Journal:  Behring Inst Mitt       Date:  1993-08

3.  Mast cell degranulation inhibits IL-2-induced microvascular protein leakage.

Authors:  M J Edwards; B T Heniford; F N Miller
Journal:  J Surg Res       Date:  1992-05       Impact factor: 2.192

4.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid.

Authors:  O I Aruoma; B Halliwell; B M Hoey; J Butler
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

5.  Involvement of sulfhydryl groups in the oxidative modulation of particulate lung guanylate cyclase by nitric oxide and N-methyl-N'nitro-N-nitrosoguanidine.

Authors:  J M Braughler
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

6.  Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function.

Authors:  G R Bernard; W D Lucht; M E Niedermeyer; J R Snapper; M L Ogletree; K L Brigham
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Heparin-released superoxide dismutase inhibits postischemic leukocyte adhesion to venular endothelium.

Authors:  M Becker; M D Menger; H A Lehr
Journal:  Am J Physiol       Date:  1994-09

8.  Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage.

Authors:  I Kurose; D C Anderson; M Miyasaka; T Tamatani; J C Paulson; R F Todd; J R Rusche; D N Granger
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

9.  Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.

Authors:  C D Spies; K Reinhart; I Witt; A Meier-Hellmann; L Hannemann; D L Bredle; W Schaffartzik
Journal:  Crit Care Med       Date:  1994-11       Impact factor: 7.598

10.  Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice.

Authors:  H Xu; J A Gonzalo; Y St Pierre; I R Williams; T S Kupper; R S Cotran; T A Springer; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  5 in total

1.  N-acetylcysteine protects striated muscle in a model of compartment syndrome.

Authors:  Stephen R Kearns; David E O'Briain; Katherine M Sheehan; Cathal Kelly; David Bouchier-Hayes
Journal:  Clin Orthop Relat Res       Date:  2010-03-23       Impact factor: 4.176

2.  N-acetylcysteine induces shedding of selectins from liver and intestine during orthotopic liver transplantation.

Authors:  F J Taut; H Schmidt; C M Zapletal; J C Thies; C Grube; J Motsch; E Klar; E Martin
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 3.  Pathoanatomy and clinical correlates of the immunoinflammatory response following orthopaedic trauma.

Authors:  Benjamin W Sears; Michael D Stover; John Callaci
Journal:  J Am Acad Orthop Surg       Date:  2009-04       Impact factor: 3.020

Review 4.  N-acetylcysteine for sepsis and systemic inflammatory response in adults.

Authors:  Tamas Szakmany; Balázs Hauser; Peter Radermacher
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 5.  Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.

Authors:  Maria Elisa Lopes-Pires; Jéssica Oliveira Frade-Guanaes; Gregory J Quinlan
Journal:  Antioxidants (Basel)       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.